Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style.

Fuentes B, Gállego J, Gil-Nuñez A, Morales A, Purroy F, Roquer J, Segura T, Tejada J, Lago A, Díez-Tejedor E, Alonso de Leciñana M, Alvarez-Sabin J, Arenillas J, Calleja S, Casado I, Castellanos M, Castillo J, Dávalos A, Díaz-Otero F, Egido JA, López-Fernández JC, Freijo M, García Pastor A, Gilo F, Irimia P, Maestre J, Masjuan J, Martí-Fábregas J, Martínez-Sánchez P, Martínez-Vila E, Molina C, Nombela F, Ribó M, Rodríguez-Yañez M, Rubio F, Serena J, Simal P, Vivancos J; Comitéad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN..

Neurologia. 2012 Nov-Dec;27(9):560-74. doi: 10.1016/j.nrl.2011.06.002. Epub 2011 Sep 3. English, Spanish.

2.

Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.

Fuentes B, Gállego J, Gil-Nuñez A, Morales A, Purroy F, Roquer J, Segura T, Tejada J, Lago A, Díez-Tejedor E; por el Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN:., Alonso de Leciñana M, Alvarez-Sabin J, Arenillas J, Calleja S, Casado I, Castellanos M, Castillo J, Dávalos A, Díaz-Otero F, Egido JA, López-Fernández JC, Freijo M, García Pastor A, Gilo F, Irimia P, Maestre J, Masjuan J, Martí-Fábregas J, Martínez-Sánchez P, Martínez-Vila E, Molina C, Nombela F, Ribó M, Rodríguez-Yañez M, Rubio F, Serena J, Simal P, Vivancos J; Committee of the Cerebrovascular Diseases Study Group of The Spanish Neurological..

Neurologia. 2014 Apr;29(3):168-83. doi: 10.1016/j.nrl.2011.06.003. Epub 2011 Sep 19. Review. English, Spanish.

3.

Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack.

Scott DP, Greenfield JR, Bramah V, Alford J, Bennett C, Markus R, Campbell LV.

Intern Med J. 2010 Apr;40(4):275-80. doi: 10.1111/j.1445-5994.2009.01941.x. Epub 2009 Mar 9.

PMID:
19383060
4.

Secondary prevention of stroke and transient ischaemic attack.

Lawrence M, Fraser H, Woods C, McCall J.

Nurs Stand. 2011 Nov 2-8;26(9):41-6.

PMID:
22165550
5.

[Secondary prophylaxis after ischemic stroke and transitoric ischemic attack].

Russell D, Lund C, Dahl A.

Tidsskr Nor Laegeforen. 2007 May 17;127(10):1379-82. Review. Norwegian.

6.

Lifestyle interventions for secondary disease prevention in stroke and transient ischaemic attack: a systematic review.

Lennon O, Galvin R, Smith K, Doody C, Blake C.

Eur J Prev Cardiol. 2014 Aug;21(8):1026-39. doi: 10.1177/2047487313481756. Epub 2013 Mar 11. Review.

PMID:
23478741
7.

Knowledge of stroke risk factors among primary care patients with previous stroke or TIA: a questionnaire study.

Sloma A, Backlund LG, Strender LE, Skånér Y.

BMC Fam Pract. 2010 Jun 15;11:47. doi: 10.1186/1471-2296-11-47.

8.

Therapeutic interventions for prevention of recurrent ischemic stroke.

Kirshner HS.

Am J Manag Care. 2008 Jun;14(6 Suppl 2):S212-26. Review.

9.

Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.

Atanassova PA, Chalakova NT, Dimitrov BD.

Cerebrovasc Dis. 2008;25(3):225-33. doi: 10.1159/000113860. Epub 2008 Jan 24.

PMID:
18216464
10.

South African guideline for management of ischaemic stroke and transient ischaemic attack 2010: a guideline from the South African Stroke Society (SASS) and the SASS Writing Committee.

Bryer A, Connor M, Haug P, Cheyip B, Staub H, Tipping B, Duim W, Pinkney-Atkinson V.

S Afr Med J. 2010 Nov 10;100(11 Pt 2):747-78.

PMID:
21081029
12.

Atorvastatin: its clinical role in cerebrovascular prevention.

Gaspardone A, Arca M.

Drugs. 2007;67 Suppl 1:55-62. Review.

PMID:
17910521
13.

Preventing strokes: the assessment and management of people with transient ischaemic attack.

Gommans J, Barber PA, Fink J.

N Z Med J. 2009 Apr 24;122(1293):3556. Review.

PMID:
19448791
14.

Survey of blood pressure control status in patients with ischemic stroke or transient ischemic attack in China.

Wang Y, Wu D, Zhou Y, Zhao X, Wang C, Liu L, Liao X, Wang Y.

Neurol Res. 2008 May;30(4):348-55. doi: 10.1179/174313208X300323.

PMID:
18544250
15.

Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases.

Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B, Szapary L, Feher G.

Int J Cardiol. 2011 Apr 14;148(2):131-8. doi: 10.1016/j.ijcard.2010.08.012. Epub 2010 Sep 16. Review.

PMID:
20843571
16.

Differentiating ischemic stroke subtypes: risk factors and secondary prevention.

Kirshner HS.

J Neurol Sci. 2009 Apr 15;279(1-2):1-8. doi: 10.1016/j.jns.2008.12.012. Epub 2009 Jan 29. Review.

PMID:
19185319
17.

Secondary prevention of ischaemic stroke and TIA.

Diener HC.

Cardiovasc J Afr. 2008 Jul-Aug;19(4):229. No abstract available.

18.

Risk factor management for stroke prevention.

Prabhakaran S, Chong JY.

Continuum (Minneap Minn). 2014 Apr;20(2 Cerebrovascular Disease):296-308. doi: 10.1212/01.CON.0000446102.82420.64. Review.

PMID:
24699482
19.

Medical therapy for secondary prevention of stroke.

Regesta G.

Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):555-62. Review.

PMID:
12450231
20.

Does telephone follow-up improve blood pressure after minor stroke or TIA?

Adie K, James MA.

Age Ageing. 2010 Sep;39(5):598-603. doi: 10.1093/ageing/afq085. Epub 2010 Jul 27.

PMID:
20667838

Supplemental Content

Support Center